NasdaqGS - Nasdaq Real Time Price USD

Integra LifeSciences Holdings Corporation (IART)

28.36 -0.05 (-0.18%)
As of 11:48 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,541,573.00
1,541,573.00
1,557,666.00
1,542,448.00
1,371,868.00
Cost of Revenue
656,838.00
656,838.00
587,355.00
597,808.00
520,834.00
Gross Profit
884,735.00
884,735.00
970,311.00
944,640.00
851,034.00
Operating Expense
773,209.00
773,209.00
731,391.00
747,410.00
699,664.00
Operating Income
111,526.00
111,526.00
238,920.00
197,230.00
151,370.00
Net Non Operating Interest Income Expense
-34,175.00
-34,175.00
-37,677.00
-43,658.00
-62,284.00
Other Income Expense
3,718.00
3,718.00
12,651.00
61,105.00
4,434.00
Pretax Income
81,069.00
81,069.00
213,894.00
214,677.00
93,520.00
Tax Provision
13,328.00
13,328.00
33,344.00
45,602.00
-40,372.00
Net Income Common Stockholders
67,741.00
67,741.00
180,550.00
169,075.00
133,892.00
Diluted NI Available to Com Stockholders
67,741.00
67,741.00
180,550.00
169,075.00
133,892.00
Basic EPS
0.85
0.85
2.18
2.00
1.59
Diluted EPS
0.84
0.84
2.16
1.98
1.57
Basic Average Shares
80,089.00
80,089.00
82,997.00
84,698.00
84,337.00
Diluted Average Shares
80,337.00
80,337.00
83,516.00
85,485.00
85,228.00
Total Operating Income as Reported
111,526.00
111,526.00
238,920.00
197,230.00
151,370.00
Total Expenses
1,430,047.00
1,430,047.00
1,318,746.00
1,345,218.00
1,220,498.00
Net Income from Continuing & Discontinued Operation
67,741.00
67,741.00
180,550.00
169,075.00
133,892.00
Normalized Income
67,741.00
67,741.00
180,006.46
136,155.79
133,892.00
Interest Income
17,202.00
17,202.00
11,917.00
6,737.00
9,297.00
Interest Expense
51,377.00
51,377.00
49,594.00
50,395.00
71,581.00
Net Interest Income
-34,175.00
-34,175.00
-37,677.00
-43,658.00
-62,284.00
EBIT
132,446.00
132,446.00
263,488.00
265,072.00
165,101.00
EBITDA
255,958.00
255,958.00
381,787.00
384,908.00
281,132.00
Reconciled Cost of Revenue
545,702.00
545,702.00
482,938.00
494,886.00
432,560.00
Reconciled Depreciation
123,512.00
123,512.00
118,299.00
119,836.00
116,031.00
Net Income from Continuing Operation Net Minority Interest
67,741.00
67,741.00
180,550.00
169,075.00
133,892.00
Total Unusual Items Excluding Goodwill
--
--
644.00
41,798.00
--
Total Unusual Items
--
--
644.00
41,798.00
--
Normalized EBITDA
255,958.00
255,958.00
381,143.00
343,110.00
281,132.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
100.46
8,878.79
--
12/31/2020 - 8/16/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNMD CONMED Corporation
64.31
+3.89%
 
NARI Inari Medical, Inc.
38.45
+1.00%
 
ITGR Integer Holdings Corporation
108.23
-2.63%
 
QDEL QuidelOrtho Corporation
40.00
+0.77%
 
PODD Insulet Corporation
166.35
+1.33%
 
INSP Inspire Medical Systems, Inc.
237.76
+2.92%
 
EW Edwards Lifesciences Corporation
86.97
-1.18%
 
NVRO Nevro Corp.
11.48
-1.25%
 
LIVN LivaNova PLC
55.04
-0.11%
 
BRKR Bruker Corporation
81.30
+0.87%